Verve Therapeutics Inc (VERV)
6.33
-0.09
(-1.40%)
USD |
NASDAQ |
Nov 12, 15:07
Verve Therapeutics Revenue (Annual): 11.76M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 11.76M |
Date | Value |
---|---|
December 31, 2022 | 1.941M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
1.941M
Minimum
2022
11.76M
Maximum
2023
6.850M
Average
6.850M
Median
Revenue (Annual) Benchmarks
Ardelyx Inc | 124.46M |
Biomarin Pharmaceutical Inc | 2.419B |
Sage Therapeutics Inc | 86.46M |
ALX Oncology Holdings Inc | -- |
Immuneering Corp | -- |